MRI has become a central part of diagnosing and managing prostate cancer, but private payer coverage has not kept up with this technological trend, reported authors of a recent Journal of the American College of Radiology study.
Contrast-enhanced ultrasound may be more accurate than CT or MRI in identifying cancerous tumors in the kidneys and could reduce unnecessary biopsies and surgical procedures by half, according to research presented at the 2018 International Contrast Ultrasound Society’s Bubble Conference in Chicago.
Authors of a recent Journal of Nuclear Medicine study have discovered potential for misdiagnosis when relying solely on prostate-specific membrane antigen (PSMA) PET imaging in prostate cancer staging.
Researchers found that incorporating lung nodule features and patient-specific characteristics improved the positive predictive ability of a cancer screening model while maintaining low-dose CT scan sensitivity, according to research published in the Journal of the American College of Radiology.
The U.S. Preventative Services Task Force (USPSTF) issued updated cervical cancer screening guidelines Aug. 21 that stated a human papillomavirus (HPV) test alone is as effective as the commonly used Pap smear.
Veterans who utilize Medicare and other fee-for-service health systems for prostate cancer care are more likely to receive guideline-discordant imaging than those treated at the Veterans Health Administration (VA), according to a study published Aug. 17 in JAMA Network Open.
Breast density laws have been on the books since 2009, with states increasingly joining the upward trend. But new research surveying more than 1,000 women found many remain confused and misinformed about such legislation.
New research from the American Cancer Society found cancer patients who reported experiencing better communication with a provider typically received more efficient care, fewer office visits and improved outcomes.
Researchers at Massachusetts Institute of Technology (MIT) have created a machine-learning technique that reduces the toxic chemotherapy and radiotherapy doses for patients with the most aggressive form of brain cancer.